{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:34:35Z","timestamp":1794684875787,"version":"4.9.1"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pnpbp.2026.111774","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:03:27Z","timestamp":1781208207000},"page":"111774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Beyond categorical boundaries: Common molecular and cellular pathways in autism spectrum disorder and schizophrenia"],"prefix":"10.1016","volume":"148","author":[{"given":"Nahi Sabih","family":"Alruwaili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Shokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda M.","family":"Bogari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhair","family":"Alhelfawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarak","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111774_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.70038","article-title":"Psilocybin as transformative fast-acting antidepressant: pharmacological properties and molecular mechanisms","volume":"39","author":"Adebo","year":"2025","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euroneuro.2024.04.012","article-title":"Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: a narrative review and recommendation for clinical practice","volume":"84","author":"Agid","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ph18111644","article-title":"Review of autism Spectrum disorder (ASD): epidemiology, aetiology, pathology, and pharmacological treatment","volume":"18","author":"Aljead","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/children8050318","article-title":"Risperidone or aripiprazole can resolve autism core signs and symptoms in young children: case study","volume":"8","author":"Alsayouf","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0025","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1007\/s10787-025-01940-6","article-title":"Enterogenic dementia: defining the gut\u2013brain axis and the role of inflammatory bowel disease in cognitive impairment","volume":"33","author":"Alshammari","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/cn3002174","article-title":"Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior","volume":"4","author":"Altieri","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0035","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ibneur.2023.03.011","article-title":"Correlation of mutated gene and signalling pathways in ASD","volume":"14","author":"Apte","year":"2023","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-023-00993-x","article-title":"Immunoregulatory and\/or anti-inflammatory agents for the management of core and associated symptoms in individuals with autism spectrum disorder: a narrative review of randomized, placebo-controlled trials","author":"Arteaga-Henr\u00edquez","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0045","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/cimb47090721","article-title":"Neurodevelopmental impact of maternal immune activation and autoimmune disorders, environmental toxicants and folate metabolism on autism Spectrum disorder","volume":"47","author":"Ayoub","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ajmg.a.36847","article-title":"Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility","volume":"167","author":"Bacchelli","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000491489","article-title":"The sex chromosome hypothesis of schizophrenia: alive, dead, or forgotten? A commentary and review","volume":"4","author":"Bache","year":"2018","journal-title":"Complex Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13020310","article-title":"Prenatal SSRI exposure increases the risk of autism in rodents via aggravated oxidative stress and neurochemical changes in the brain","volume":"13","author":"Bhat","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/receptors3010004","article-title":"D1-like and D2-like dopamine receptors in the rat prefrontal cortex: impacts of genetic generalized epilepsies and social behavioral deficits","volume":"3","author":"Birioukova","year":"2024","journal-title":"Receptors"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/YCO.0000000000000699","article-title":"Estrogens in schizophrenia: progress, current challenges and opportunities","volume":"34","author":"Brand","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100071","article-title":"Targeting the serotonergic system in the treatment of neurodegenerative diseases\u2014emerging therapies and unmet challenges","volume":"77","author":"Br\u00fcge","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0080","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1097\/MS9.0000000000003309","article-title":"Cobenfy (xanomeline-trospium): a breakthrough FDA-approved therapy redefining schizophrenia treatment","volume":"87","author":"Bukhari","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0085","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0090","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2174\/1570159X17666190603170511","article-title":"Synaptic elimination in neurological disorders","volume":"17","author":"Cardozo","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsycho.2015.10.013","article-title":"A quantitative review of the postmortem evidence for decreased cortical N-methyl-d-aspartate receptor expression levels in schizophrenia: how can we link molecular abnormalities to mismatch negativity deficits?","volume":"116","author":"Catts","year":"2016","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2014.00070","article-title":"GABAergic signaling as therapeutic target for autism spectrum disorders","volume":"2","author":"Cellot","year":"2014","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/19585969.2025.2502028","article-title":"5-HT6 receptors: contemporary views on their neurobiological and pharmacological relevance in neuropsychiatric disorders","volume":"27","author":"Chagraoui","year":"2025","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0110","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/schbul\/sbae044","article-title":"Shared genetic determinants of schizophrenia and autism Spectrum disorder implicate opposite risk patterns: a genome-wide analysis of common variants","volume":"50","author":"Chen","year":"2024","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091345","article-title":"The histaminergic system in neuropsychiatric disorders","volume":"11","author":"Cheng","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012233","article-title":"Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation","volume":"5","author":"Cheung","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21207777","article-title":"Neurotrophic factor bdnf, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer","volume":"21","author":"Colucci-D\u2019amato","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000604","article-title":"Increased expression of schizophrenia-associated gene C4 leads to hypoconnectivity of prefrontal cortex and reduced social interaction","volume":"18","author":"Comer","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/jpet.116.237412","article-title":"Estrogen signaling as a therapeutic target in neurodevelopmental disorders","volume":"360","author":"Crider","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0140","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1007\/s12035-022-02976-3","article-title":"Linking inflammation, aberrant glutamate-dopamine interaction, and post-synaptic changes: translational relevance for schizophrenia and antipsychotic treatment: a systematic review","volume":"59","author":"de Bartolomeis","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0145","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/jcm8091304","article-title":"Prevalence of non-affective psychoses in individuals with autism spectrum disorders: a systematic review","volume":"8","author":"De Giorgi","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1395867","article-title":"NMDA antagonist agents for the treatment of symptoms in autism spectrum disorder: a systematic review and meta-analysis","volume":"15","author":"Dessus-Gilbert","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/7021071","article-title":"Efficacy of Memantine in schizophrenic patients: a systematic review","volume":"2017","author":"Di Iorio","year":"2017","journal-title":"J. Amino Acids"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41380-022-01708-2","article-title":"Advancing preclinical models of psychiatric disorders with human brain organoid cultures","volume":"28","author":"Dixon","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0165","first-page":"1","article-title":"Glutamatergic dysfunction and synaptic ultrastructural alterations in schizophrenia and autism spectrum disorder: evidence from human and rodent studies","volume":"22","author":"Eltokhi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/jgen.10404","article-title":"Mechanisms of X chromosome dosage compensation","volume":"3","author":"Ercan","year":"2014","journal-title":"J. Genomics"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0175","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","article-title":"The histamine H 3 receptor: an attractive target for the treatment of cognitive disorders","volume":"154","author":"Esbenshade","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030521","article-title":"Autism spectrum disorders and the gut microbiota","volume":"11","author":"Fattorusso","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1123462","article-title":"A review of probiotics in the treatment of autism spectrum disorders: perspectives from the gut\u2013brain axis","volume":"14","author":"Feng","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/2045125316672136","article-title":"Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole","volume":"7","author":"Frankel","year":"2017","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0200","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s43440-025-00782-x","article-title":"The cortisol axis and psychiatric disorders: an updated review","volume":"77","author":"George","year":"2025","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/YCO.0000000000000696","article-title":"Abnormal synaptic pruning during adolescence underlying the development of psychotic disorders","volume":"34","author":"Germann","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.schres.2019.01.030","article-title":"Stress during critical periods of development and risk for schizophrenia","volume":"213","author":"Gomes","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0215","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1111\/bph.12720","article-title":"Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties","volume":"171","author":"Guardiola-Lemaitre","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0220","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.neubiorev.2021.10.025","article-title":"The dual hit hypothesis of schizophrenia: evidence from animal models","volume":"131","author":"Guerrin","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2026.1762930","article-title":"From synapse to system: mechanistic pathways of neural signaling dysfunction in psychiatric disorders","volume":"14","author":"Gupta","year":"2026","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0230","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/1389201019666180620112528","article-title":"Glutamatergic deficits in schizophrenia \u2013 biomarkers and pharmacological interventions within the ketamine model","volume":"19","author":"Haaf","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0235","first-page":"2050","article-title":"Crosstalk between microglia and neurons in Neurotrauma: an overview of the underlying mechanisms","volume":"20","author":"Haidar","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660342","article-title":"Cholinergic system and its therapeutic importance in inflammation and autoimmunity","volume":"12","author":"Halder","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0245","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/brainsci12040460","article-title":"Altered cytokine and BDNF levels in individuals with autism spectrum disorders","volume":"12","author":"Han","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/medicines7090055","article-title":"Pitolisant and other Histamine-3 receptor antagonists\u2014An update on therapeutic potentials and clinical prospects","volume":"7","author":"Harwell","year":"2020","journal-title":"Medicines"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0255","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5498\/wjp.v13.i6.262","article-title":"Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials","volume":"13","author":"Hellings","year":"2023","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2011.11.020","article-title":"Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence","volume":"204","author":"Hillard","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: An update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11051482","article-title":"Brain-derived neurotrophic factor (BDNF) in mechanisms of autistic-like behavior in BTBR mice: crosstalk with the dopaminergic brain system","volume":"11","author":"Ilchibaeva","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11302-025-10114-6","article-title":"The potential role of adenosinergic pathway and methylxanthines in Parkinson\u2019s disease: blowing in the wind or not","volume":"22","author":"Ismail","year":"2026","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0280","article-title":"GABAergic system dysfunction and challenges in schizophrenia research","volume":"9","author":"Jahangir","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0285","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1016\/j.apsb.2025.07.002","article-title":"Biased signaling via serotonin 5-HT2Areceptor: from structural aspects to in vitro and in vivo pharmacology","volume":"15","author":"Jastrz\u0119bski","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0290","first-page":"191","article-title":"Alpha7 nAChR agonists for cognitive deficit and negative symptoms in schizophrenia: a meta-analysis of randomized double-blind controlled trials","volume":"29","author":"Jin","year":"2017","journal-title":"Shanghai Arch. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/npp.2011.199","article-title":"Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia","volume":"37","author":"Jones","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.806618","article-title":"The signaling and pharmacology of the dopamine D1 receptor","volume":"15","author":"Jones-Tabah","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0305","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/aur.2659","article-title":"Autism spectrum disorder and schizophrenia: An updated conceptual review","volume":"15","author":"Jutla","year":"2022","journal-title":"Autism Res."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0310","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbi.2024.05.033","article-title":"Synaptic pruning in schizophrenia is not classical","volume":"120","author":"Kalinowski","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0315","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-018-0203-y","article-title":"Plasma anandamide concentrations are lower in children with autism spectrum disorder","volume":"9","author":"Karhson","year":"2018","journal-title":"Mol. Autism."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1439176","article-title":"Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review","volume":"15","author":"Karimi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0325","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","article-title":"SE 242084, a selective and brain penetrant 5-HT(2C) receptor antagonist","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0330","article-title":"Brain structural and functional alteration in movement disorders: a narrative review of markers and their dynamic changes","volume":"100130","author":"Khan","year":"2025","journal-title":"NeuroMarkers"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0335","first-page":"149","article-title":"A comparison of autistic like traits in the relatives of patients with autism and schizophrenia spectrum disorder","volume":"13","author":"Khanjani","year":"2018","journal-title":"Iran. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177419","article-title":"Dysregulation of serotonergic neurotransmission in Parkinson disease: a key duet","volume":"995","author":"Khowdiary","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114168","article-title":"On the role of serotonin 5-HT1A receptor in autistic-like behavior: \u0441ross talk of 5-HT and BDNF systems","volume":"438","author":"Kondaurova","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.700968","article-title":"Dopaminergic dysregulation in syndromic autism Spectrum disorders: insights from genetic mouse models","volume":"15","author":"Kosillo","year":"2021","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0355","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-med-061109-134644","article-title":"Toward fulfilling the promise of molecular medicine in fragile X syndrome","volume":"62","author":"Krueger","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0360","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/genes16050478","article-title":"Autism Spectrum disorder: genetic mechanisms and inheritance patterns","volume":"16","author":"La Monica","year":"2025","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105549","article-title":"Parvalbumin interneuron dysfunction in neurological disorders: focus on epilepsy and Alzheimer\u2019s disease","volume":"25","author":"Leitch","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0370","article-title":"Schizophrenia","volume":"11","author":"Leucht","year":"2025","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0375","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2022-100823","article-title":"A glimpse of gender differences in schizophrenia","volume":"35","author":"Li","year":"2022","journal-title":"Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0380","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216231120","article-title":"Whole-brain mapping of histaminergic projections in mouse brain","volume":"120","author":"Lin","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0385","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/schbul\/sbq086","article-title":"Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia","volume":"38","author":"Linderholm","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12010210","article-title":"The impact of microglia on neurodevelopment and brain function in autism","volume":"12","author":"Luo","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0395","article-title":"Diminished activity-dependent BDNF signaling differentially causes autism-like behavioral deficits in male and female mice","volume":"14","author":"Ma","year":"2023","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0400","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00787-019-01333-5","article-title":"Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Mahdavinasab","year":"2019","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0405","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2018.01.023","article-title":"Microglia and neonatal brain injury","volume":"405","author":"Mallard","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0410","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cercor\/bhy061","article-title":"Microglial pruning of synapses in the prefrontal cortex during adolescence","volume":"29","author":"Mallya","year":"2019","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0415","article-title":"Dopamine in autism Spectrum disorders\u2014focus on D2\/D3 partial agonists and their possible use in treatment","volume":"12","author":"Mandic-Maravic","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0420","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164799","article-title":"Age-related differences in striatal dopamine D1 receptors mediate subjective drug effects","volume":"133","author":"Manza","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0425","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.yhbeh.2009.02.004","article-title":"Potential hormonal mechanisms of attention-deficit\/hyperactivity disorder and major depressive disorder: a new perspective","volume":"55","author":"Martel","year":"2009","journal-title":"Horm. Behav."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0430","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.48372","article-title":"Multiple clinical indications of mifepristone: a systematic review","author":"Mathew","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0435","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1523\/JNEUROSCI.0937-11.2011","article-title":"\u03b14\u03b22 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief","volume":"31","author":"McGranahan","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0440","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/aur.70121","article-title":"Comparison of adulthood outcomes in autism Spectrum disorder with and without regression: a population-based birth cohort study","volume":"18","author":"Minami","year":"2025","journal-title":"Autism Res."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0445","article-title":"Sex differences in schizophrenia: symptomatology, treatment efficacy and adverse effects","volume":"16","author":"Moniem","year":"2025","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073861","article-title":"Autism Spectrum disorder: focus on glutamatergic neurotransmission","volume":"23","author":"Montanari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0455","doi-asserted-by":"crossref","first-page":"S835","DOI":"10.1016\/j.euroneuro.2017.08.097","article-title":"An inherited distal 16P11.2 deletion demonstrates variable expressivity and incomplete penetrance for psychiatric illness as well as association with Rhizomelic shortening: a case report","volume":"29","author":"Morris","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105840","article-title":"Association of complement component 4 with neuroimmune abnormalities in the subventricular zone in schizophrenia and autism spectrum disorders","volume":"173","author":"Mou","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-01930-0","article-title":"5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction","volume":"12","author":"Nakao","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094764","article-title":"Molecular alterations of the endocannabinoid system in psychiatric disorders","volume":"23","author":"Navarro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0475","article-title":"Mapping autism\u2019s research landscape: trends in autism screening and its alignment with sustainable development goals","volume":"14","author":"Nedungadi","year":"2023","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051074","article-title":"Prevention or amelioration of autism-like symptoms in animal models: will it bring us closer to treating human ASD?","volume":"20","author":"Ornoy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0485","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1503\/jpn.170094","article-title":"Neuroanatomical phenotypes in mental illness: identifying convergent and divergent cortical phenotypes across autism. ADHD and schizophrenia","volume":"43","author":"Park","year":"2018","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0490","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopsych.2024.03.014","article-title":"Muscarinic receptor activators as novel treatments for schizophrenia","volume":"96","author":"Paul","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0495","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neulet.2011.01.039","article-title":"Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation","volume":"491","author":"Pedrini","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0500","doi-asserted-by":"crossref","DOI":"10.5498\/wjp.v15.i6.105409","article-title":"Targeting muscarinic receptors in schizophrenia treatment: novel antipsychotic xanomeline\/trospium chloride","volume":"15","author":"Pej\u010di\u0107","year":"2025","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2022.100056","article-title":"Dysregulation of complement system in neuropsychiatric disorders: a mini review","volume":"7","author":"Perez Sierra","year":"2022","journal-title":"Biomark. Neuropsychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0510","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1523\/JNEUROSCI.1377-08.2009","article-title":"NKCC1-dependent GABAergic excitation drives synaptic network maturation during early hippocampal development","volume":"29","author":"Pfeffer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0515","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/2167702614540646","article-title":"A two-hit model of autism: adolescence as the second hit","volume":"3","author":"Picci","year":"2015","journal-title":"Clin. Psychol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0520","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1233743","article-title":"The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice","volume":"10","author":"Pogorelov","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0530","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neubiorev.2018.09.012","article-title":"Social brain, social dysfunction and social withdrawal","volume":"97","author":"Porcelli","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13060709","article-title":"The underlying neurobiological mechanisms of psychosis: focus on neurotransmission dysregulation, Neuroinflammation, oxidative stress, and mitochondrial dysfunction","volume":"13","author":"Rawani","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0540","article-title":"Xanomeline-Trospium chloride as a new paradigm in the treatment of schizophrenia through muscarinic modulation: a renewed Hope in psychiatric care","volume":"18","author":"Raza","year":"2026","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-01119-3","article-title":"Towards in vivo imaging of functionally active 5-HT1A receptors in schizophrenia: concepts and challenges","volume":"11","author":"Razakarivony","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0550","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/hbm.24976","article-title":"mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia","volume":"41","author":"R\u00e9gio Brambilla","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0555","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.neuron.2018.05.018","article-title":"Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert","volume":"98","author":"Reiner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0560","article-title":"Recognizing psychosis in autism Spectrum disorder","volume":"13","author":"Ribolsi","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0565","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4137\/IJTR.S2129","article-title":"L-tryptophan: basic metabolic functions, behavioral research and therapeutic indications","volume":"2","author":"Richard","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0570","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41386-018-0148-z","article-title":"Sex differences and the neurobiology of affective disorders","volume":"44","author":"Rubinow","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0575","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.tips.2021.09.005","article-title":"Pharmacological tools to target NKCC1 in brain disorders","volume":"42","author":"Savardi","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0580","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.yfrne.2006.09.004","article-title":"Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS","volume":"27","author":"Scharfman","year":"2006","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0585","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11011-025-01739-y","article-title":"Rewiring brain immunity: targeting microglial metabolism for neuroprotection in neurodegenerative disorders","volume":"40","author":"Shokr","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0590","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroscience.2025.02.023","article-title":"HMGB1: different secretion pathways with pivotal role in epilepsy and major depressive disorder","volume":"570","author":"Shokr","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0595","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.neuron.2010.02.014","article-title":"A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia","volume":"65","author":"Simpson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0600","first-page":"43","article-title":"Xanomeline and Trospium: a potential fixed drug combination (FDC) for schizophrenia\u2014a brief review of current data","volume":"19","author":"Singh","year":"2022","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0605","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1098\/rstb.2012.0313","article-title":"Endocannabinoids in nervous system health and disease: the big picture in a nutshell","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0610","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0615","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3892\/etm.2016.3531","article-title":"Estrogen therapy increases BDNF expression and improves post-stroke depression in ovariectomy-treated rats","volume":"12","author":"Su","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0620","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.3390\/ijms26146619","article-title":"Autistic traits in schizophrenia: immune mechanisms and inflammatory biomarkers","volume":"26","author":"Suprunowicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00205","article-title":"Multi-target pharmacology: possibilities and limitations of the \u201cskeleton key approach\u201d from a medicinal chemist perspective","volume":"6","author":"Talevi","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0630","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.17219\/acem\/197425","article-title":"Beyond the boundaries: transitioning from categorical to dimensional paradigms in mental health diagnostics","volume":"33","author":"Tanaka","year":"2024","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0635","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2011.52","article-title":"Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia","volume":"1","author":"Tarabeux","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0640","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1002\/mds.28698","article-title":"Vesicular acetylcholine transporter alters cholinergic tone and synaptic plasticity in DYT1 dystonia","volume":"36","author":"Tassone","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0645","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gde.2020.06.013","article-title":"Microglial ontogeny, diversity and neurodevelopmental functions","volume":"65","author":"Thion","year":"2020","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0650","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ntr\/nty034","article-title":"Alpha7 nicotinic receptors as therapeutic targets in schizophrenia","volume":"21","author":"Tregellas","year":"2019","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0655","article-title":"Dynamic regulation of NMDAR function in the adult brain by the stress hormone corticosterone","volume":"1\u201314","author":"Tse","year":"2012","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0660","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.neuron.2012.09.004","article-title":"Neuronal dynamics and neuropsychiatric disorders: toward a translational paradigm for dysfunctional large-scale networks","volume":"75","author":"Uhlhaas","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112946","article-title":"\u03917 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats","volume":"397","author":"Unal","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0670","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-025-03455-8","article-title":"Using the excitation\/inhibition ratio to optimize the classification of autism and schizophrenia","volume":"15","author":"Usc\u0103tescu","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0675","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1007\/s10803-021-05046-0","article-title":"Autism spectrum disorder and clinical high risk for psychosis: a systematic review and meta-analysis","volume":"52","author":"Vaquerizo-Serrano","year":"2022","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0680","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/aian.aian_521_24","article-title":"Transition of care for pediatric neurologic disorders \u2013 are we there yet?","volume":"28","author":"Vinayan","year":"2025","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106529","article-title":"Psychedelic experiences elicited by serotonergic psychedelics: molecular mechanisms and functional connectivity changes in the brain","volume":"181","author":"Vollebregt","year":"2026","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0690","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bandc.2009.10.013","article-title":"Developmental changes in dopamine neurotransmission in adolescence: behavioral implications and issues in assessment","volume":"72","author":"Wahlstrom","year":"2010","journal-title":"Brain Cogn."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111411","article-title":"Understanding autism: causes, diagnosis, and advancing therapies","volume":"227","author":"Wang","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0700","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/brainsci12040439","article-title":"Subcortical brain morphometry differences between adults with autism Spectrum disorder and schizophrenia","volume":"12","author":"Weerasekera","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0705","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/aur.3123","article-title":"Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder","volume":"17","author":"Wegiel","year":"2024","journal-title":"Autism Res."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0710","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.840266","article-title":"Complement dependent synaptic reorganisation during critical periods of brain development and risk for psychiatric disorder","volume":"16","author":"Westacott","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0715","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112441","article-title":"Changes in striatal medium spiny neuron morphology resulting from dopamine depletion are reversible","volume":"9","author":"Witzig","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0720","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.27163","article-title":"Hippocampal availability of the \u03b17 nicotinic acetylcholine receptor in recent-onset psychosis","volume":"7","author":"Wong","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0725","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.87","article-title":"Altered expression of histamine signaling genes in autism spectrum disorder","volume":"7","author":"Wright","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0730","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/aps.2017.172","article-title":"GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia","volume":"39","author":"Xu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47121032","article-title":"Molecular basis of GABA aminotransferase inhibition in epilepsy: structure, mechanisms, and drug development","volume":"47","author":"Yasir","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0740","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/0109298673252910230920151332","article-title":"Advances in the treatment of autism Spectrum disorder: current and promising strategies","volume":"31","author":"Yenkoyan","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0745","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2147\/NDT.S533813","article-title":"Maternal immune activation and neurodevelopmental disorders: integrating molecular, cellular and systems mechanisms","volume":"21","author":"Yong","year":"2025","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0750","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2147\/NDT.S64236","article-title":"Profile of minocycline and its potential in the treatment of schizophrenia","volume":"10","author":"Zhang","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0755","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-0699-8","article-title":"Genetic evidence of gender difference in autism spectrum disorder supports the female-protective effect","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0760","article-title":"Advances in the treatment of cognitive impairment in schizophrenia: targeting NMDA receptor pathways","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0765","article-title":"Association of peripheral blood levels of cytokines with autism spectrum disorder: a meta-analysis","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0770","doi-asserted-by":"crossref","first-page":"31241","DOI":"10.1038\/srep31241","article-title":"Peripheral brain-derived neurotrophic factor in autism spectrum disorder: a systematic review and meta-analysis","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0775","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/eip.13021","article-title":"Autistic traits in first-episode psychosis: rates and association with 1-year recovery outcomes","volume":"15","author":"Zheng","year":"2021","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111774_bb0780","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","article-title":"Glutamate as a neurotransmitter in the healthy brain","volume":"121","author":"Zhou","year":"2014","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2026.111774_bb0785","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ajmg.b.32439","article-title":"15Q13.3 duplication in two patients with childhood-onset schizophrenia","volume":"171","author":"Zhou","year":"2016","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:16:46Z","timestamp":1785133006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":157,"alternative-id":["S0278584626001715"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111774","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond categorical boundaries: Common molecular and cellular pathways in autism spectrum disorder and schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111774"}}